货号:A212664 同义名: BRL29060 hydrochloride;BRL29060A
Paroxetine HCl is a selective serotonin-reuptake inhibitor (SSRI) with antidepressant activity.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
靶点 |
|
描述 | Paroxetine is a potent and selective serotonin reuptake inhibitor (SSRI) with Ki value of 1.1nM for inhibition of 5-HT uptake into rat cortical and hypothalamic synaptosomes in vitro. It exhibited weak affinity for muscarinic receptors (Ki=89nM). Oral administration of paroxetine produced a dose-related inhibition of [3H]-5-HT uptake (ED50=1.9mg/kg) into rat hypothalamic synaptosomes ex vivo[3]. It is currently approved indications for the treatment of depression, obsessive-compulsive disorder, panic disorder and social phobia. And it is also used in the treatment of generalized anxiety disorder, post traumatic stress disorder, premenstrual dysphoric disorder and chronic headache[4]. |
Dose | Parrot: 10 mg/kg[3] (p.o.) Rat: 10 mg/kg[4] (i.v.); 0.3 mg/kg - 10 mg/kg[5] (p.o.) |
Administration | p.o., i.v. |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT02273154 | Major Depression Disorder | Phase 4 | Unknown | December 2015 | China, Beijing ... 展开 >> Institute of mental health, Peking University Not yet recruiting Beijing, Beijing, China, 100191 Contact: Tianmei Si, PhD. 8610-82801960 si.tian-mei@163.com Principal Investigator: Tianmei Si, PhD. China, Henan Henan mental health center Recruiting Xinxiang, Henan, China, 453000 Contact: Luxian Lv, MD. 86-13837320007 lvluxian86@hotmail.com China, Hubei Wuhan mental health center Recruiting Wuhan, Hubei, China, 430000 Contact: Maosheng Fang, MD. 86-13553013182 fangmaosheng@126.com China, Jiangsu Nanjing Brain Hospital Recruiting Nanjing, Jiangsu, China, 210000 Contact: Zhijian Yao, PhD. 86-13851580276 zhijianyao@163.com China, Liaoning Dalian No.7 People's Hospital Recruiting Dalian, Liaoning, China, 116000 Contact: Shoufu Xie, MD. 86-18441168381 shoufuxie@126.com China, Shanxi Shanxi Dayi Hospital Recruiting Taiyuan, Shanxi, China, 030000 Contact: Hong Yang, MD. 86-13903414208 hongyang1964@163.com 收起 << |
NCT00445679 | Depressive Disorder, Major | Phase 3 | Completed | - | - |
NCT00445679 | - | Completed | - | - | |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.73mL 0.55mL 0.27mL |
13.67mL 2.73mL 1.37mL |
27.34mL 5.47mL 2.73mL |
CAS号 | 78246-49-8 |
分子式 | C19H21ClFNO3 |
分子量 | 365.826 |
别名 | BRL29060 hydrochloride;BRL29060A;Paroxetine (hydrochloride);FG-7051;Paroxetine HCl |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Inert atmosphere,Room Temperature |
溶解度 |
DMSO: 105 mg/mL(287.02 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 5 mg/mL(13.67 mM),配合低频超声助溶 |
动物实验配方 |